SOLNA, Sweden & ANTONY, France--(BUSINESS WIRE)--Aerocrine AB (STO:AERO.B) and Stallergenes S.A (Euronext Paris CAC small) today announce the signing of an exclusive multi-year distribution agreement for Aerocrine’s airway inflammation monitor and test Kit. The agreement will initially cover France, Italy, Poland, Turkey and the Middle East and could be extended to additional countries.
